Analia Garzotto-Rodriguez - Publications

Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies.

Journal: Therapeutic advances in medical oncology

Published: September 20, 2021

Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice.

Journal: OncoTargets and therapy

Published: June 17, 2021

Optimization of surgical treatment of advanced ovarian cancer: a Spanish expert perspective.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 29, 2018

Blood-based biomarkers for monitoring antiangiogenic therapy in non-small cell lung cancer.

Journal: Medical oncology (Northwood, London, England)

Published: July 22, 2016

Safety and efficacy of primary thromboprophylaxis in cancer patients.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 21, 2015

Erythropoiesis-stimulating agents for the treatment of chemotherapy-induced anemia: comparisons from real-world clinical experience.

Journal: Journal of blood medicine

Published: May 24, 2014

Risk factors associated with Clostridium difficile infection in adult oncology patients.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: May 22, 2014

Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: March 27, 2014